STOCK TITAN

Bed Bath & Beyond (BBBY) director boosts equity via RSU exercise and grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bed Bath & Beyond director Barclay Corbus reported several equity compensation moves. On May 15, 2026, he exercised 26,873 restricted stock units into common shares, bringing his direct common stock holdings to 105,047 shares.

He also received a new grant of 35,181 restricted stock units on May 14, 2026, which will vest at the close of business on May 14, 2027. In addition, he holds 7,816 common stock warrants originally issued on October 7, 2025, each allowing purchase of one common share at an exercise price of $15.50 per warrant through October 7, 2026.

Positive

  • None.

Negative

  • None.
Insider Corbus Barclay
Role null
Type Security Shares Price Value
Exercise Restricted Stock Units 26,873 $0.00 --
Exercise Common Stock 26,873 $0.00 --
Grant/Award Restricted Stock Units 35,181 $0.00 --
Grant/Award Common Stock Warrant 7,816 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 105,047 shares (Direct, null); Common Stock Warrant — 7,816 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested at the close of business on May 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest at the close of business on May 14, 2027. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.
RSUs exercised 26,873 shares Restricted stock units converted to common stock on May 15, 2026
Common shares held 105,047 shares Direct Bed Bath & Beyond common stock holdings after RSU exercise
New RSU grant 35,181 units Restricted stock units granted on May 14, 2026, vesting May 14, 2027
Warrant position 7,816 warrants Common stock warrants originally issued October 7, 2025
Warrant exercise price $15.50 per warrant Each warrant exercisable for one Bed Bath & Beyond common share
Warrant expiration October 7, 2026 Expiration date of Bed Bath & Beyond common stock warrants
restricted stock unit financial
"Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
common stock warrant financial
"Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock."
A common stock warrant is a tradable right that lets its holder buy a company’s common shares at a fixed price within a set time period. For investors it acts like a long‑dated option: it can magnify gains if the share price rises above the fixed price, but it also creates potential dilution because new shares are issued when warrants are used, which can reduce the value of existing shares.
exercise price financial
"Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Section 16 regulatory
"This distribution was exempt from immediate reporting under Section 16."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Corbus Barclay

(Last)(First)(Middle)
433 ASCENSION WAY
3RD FLOOR

(Street)
MURRAY UTAH 84123

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BED BATH & BEYOND, INC. [ BBBY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026M26,873A(1)105,047D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(2)05/14/2026A35,181 (2) (2)Common Stock35,181$035,181(2)D
Restricted Stock Units(1)05/15/2026M26,873 (1) (1)Common Stock26,873$00(1)D
Common Stock Warrant$15.510/07/2025A7,816(3)12/03/202510/07/2026Common Stock7,816$07,816D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested at the close of business on May 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
2. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest at the close of business on May 14, 2027. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
3. Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.
/s/ Christina Wheeler, Attorney-in-Fact05/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Barclay Corbus report for BBBY?

Barclay Corbus reported exercising 26,873 restricted stock units into Bed Bath & Beyond common stock and receiving a new grant of 35,181 restricted stock units, plus holding 7,816 common stock warrants with a $15.50 exercise price from an earlier pro-rata distribution.

How many Bed Bath & Beyond (BBBY) shares does Barclay Corbus hold after these transactions?

After exercising restricted stock units, Barclay Corbus directly holds 105,047 shares of Bed Bath & Beyond common stock. This position reflects delivery of vested RSU shares on May 15, 2026, as disclosed in the insider transaction report for these equity compensation events.

What are the details of the new restricted stock units granted to Barclay Corbus at BBBY?

Barclay Corbus received 35,181 restricted stock units, each representing a contingent right to one Bed Bath & Beyond common share. These units vest at the close of business on May 14, 2027, with vested shares delivered promptly after vesting according to the filing’s footnote disclosure.

When did Barclay Corbus’s restricted stock units at BBBY vest and convert to shares?

A block of 26,873 restricted stock units vested at the close of business on May 15, 2026 and converted into an equal number of Bed Bath & Beyond common shares. Those vested shares were delivered promptly, increasing his direct common stock holdings to 105,047 shares.

What are the terms of Barclay Corbus’s Bed Bath & Beyond common stock warrants?

Barclay Corbus holds 7,816 Bed Bath & Beyond common stock warrants originally issued on October 7, 2025 as a pro-rata distribution. Each warrant allows purchase of one common share at an exercise price of $15.50, with an expiration date of October 7, 2026.

Were Barclay Corbus’s Bed Bath & Beyond warrants part of a broader shareholder distribution?

Yes. The filing states the 7,816 warrants were originally issued on October 7, 2025 as a pro-rata distribution to all holders of Bed Bath & Beyond common stock, with each warrant exercisable for one share at a $15.50 exercise price until October 7, 2026.